Filing Details
- Accession Number:
- 0001099219-22-000186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-14 16:16:48
- Reporting Period:
- 2022-12-12
- Accepted Time:
- 2022-12-14 16:16:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099219 | Metlife Inc | MET | Life Insurance (6311) | 134075851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1535491 | Michel Khalaf | Metlife, Inc. 200 Park Avenue New York NY 10166 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-12 | 35,616 | $31.15 | 282,497 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-12 | 39,322 | $34.33 | 321,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-12 | 57,201 | $72.49 | 264,618 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-12-12 | 35,616 | $0.00 | 35,616 | $31.15 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-12-12 | 39,322 | $0.00 | 39,322 | $34.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-25 | No | 4 | M | Direct | |
| 0 | 2026-02-22 | No | 4 | M | Direct |
Footnotes
- The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees.
- The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $72.38 to $72.865, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Includes 3,798 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
- The options become exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.
- Includes 4,193 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
- The options become exercisable in three substantially equal installments on February 23, 2016, 2017 and 2018.
Billionaire Hedge Funds
